Nurami Medical announced that it received FDA 510(k) clearance for its electrospun, nanofiber-based ArtiFascia dura substitute. The Haifa, Israel-based company plans to begin U.S. sales of the resorbable dural repair graft soon. ArtiFascia assists in the process of replacing the dura mater — which protects the brain and cerebrospinal fluid (CSF) — in neurosurgery. It […]